Onesource Specialty Pharma
ONESOURCE · Pharma > Pharmaceuticals & Drugs Listing date: Jan. 24, 2025

Stock Price vs Company Growth
1d
0.1%
1w
1.4%
1m
13.6%
3m
20.6%
6m
28.8%
1y
7.1%
all
19.5%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,338 0.1%
1,075
1,819
Company Overview

Sales
1,419 Cr
Growth: 49.5%
Profit after Tax
20.1 Cr
Growth: -49.7%
Mid Cap
15,334 Cr
P/E: 744.7x
Industry P/E: 27.8x
Fundamentals

Sales (Cr) ₹ 1,419
Growth 49.5%
EBITDA 27.8%
P/S 10.8x
Dividend 0.0%
P/E 744.7x
Book Value ₹ 506
PEG Ratio 15.0x
ROE 0.3%
P/B 2.6x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

OneSource Specialty Pharma is evolved into an integrated, multimodal specialty pharmaceutical CDMO. The company specialises in offering end-to-end solutions across biologics, drug-device combinations, sterile injectables, and oral technologies (soft gelatin capsules).Awards2024-25OneSource received the Sustainable Organisation Award 2025 at the 5th Sustainability Summit hosted by UBS Forums on June 11, 2025 in Gurgaon.Received ESG award in gold category from OHSSAI Foundation.